Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia

Steullet, P, Cabungcal, J-H, Coyle, J, Didriksen, M, Gill, K, Grace, A A, Hensch, T K, LaMantia, A-S +8 more·2017·Molecular Psychiatry

Cited by (371)

Items 101–200 of 371

  1. Impaired Cognitive Function after Perineuronal Net Degradation in the Medial Prefrontal Cortex
    John W. Paylor, Eszter Wendlandt, Tara S. Freeman, Quentin Greba, Wendie N. Marks, John G. Howland, Ian Robert Winship · 2018 · eNeuro
  2. Deletion of Semaphorin 3F in Interneurons Is Associated with Decreased GABAergic Neurons, Autism-like Behavior, and Increased Oxidative Stress Cascades
    Zhu Li, Rekha Jagadapillai, Evelyne Gozal, Gregory Neal Barnes · 2019 · Molecular Neurobiology
  3. Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis
    Edward J. Goetzl, Vinod H. Srihari, Sinan Gülöksüz, Maria Ferrara, Cenk Tek, George R. Heninger · 2020 · Translational Psychiatry
  4. The impact of (ab)normal maternal environment on cortical development
    Navneet A. Vasistha, Konstantin Khodosevich · 2021 · Progress in Neurobiology
  5. Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity
    Ingram, Rachael, Kang, Heather, Lightman, Stafford, Jane, David E., Bortolotto, Zuner A., Collingridge, Graham L., Lodge, David, Volianskis, Arturas · 2018 · Neuropharmacology
  6. Increase in Seizure Susceptibility After Repetitive Concussion Results from Oxidative Stress, Parvalbumin-Positive Interneuron Dysfunction and Biphasic Increases in Glutamate/GABA Ratio
    Paul MacMullin, Nathaniel Hodgson, Ugur Damar, Henry H.C. Lee, Mustafa Qadir Hameed, Sameer C. Dhamne, Damon E. Hyde, Grace M. Conley, Nicholas J. Morriss, Jianhua Qiu et al. · 2020 · Cerebral Cortex
  7. Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life
    Magdalena Górny, Anna Bilska‐Wilkosz, Małgorzata Iciek, Marta Hereta, Kinga Kamińska, Adrianna Kamińska, Grażyna Chwatko, Zofia Rogóż, Elżbieta Lorenc‐Koci · 2020 · Antioxidants
  8. Maternal immune activation targeted to a window of parvalbumin interneuron development improves spatial working memory: Implications for autism
    Jay Nakamura, Brendan Gillespie, Andrew Stuart Gibbons, Emily Joy Jaehne, Xin Du, Aaron Chan, Anna Schroeder, Maarten van den Buuse, Suresh Sundram, Rachel Hill · 2020 · Brain Behavior and Immunity
  9. Age- and sex-specific effects of stress on parvalbumin interneurons in preclinical models: Relevance to sex differences in clinical neuropsychiatric and neurodevelopmental disorders
    Emma M. Woodward, Laurence D. Coutellier · 2021 · Neuroscience & Biobehavioral Reviews
  10. Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis
    Joshua Ryan Smith, Corey E. Hopkins, Jiangmei Xiong, James Luccarelli, Elizabeth K.B. Shultz, Simon Vandekar · 2022 · Journal of Autism and Developmental Disorders
  11. Partial TrkB receptor activation suppresses cortical epileptogenesis through actions on parvalbumin interneurons
    Feng Gu, Isabel Parada, Tao Yang, Frank M. Longo, David A. Prince · 2018 · Neurobiology of Disease
  12. Reduced inhibition underlies early life LPS exposure induced-cognitive impairment: Prevention by environmental enrichment
    Xin‐miao Wu, Mu‐Huo Ji, Xiaoyu Yin, Hanwen Gu, Tingting Zhu, Run-zhu Wang, Jianjun Yang, Jin-Chun Shen · 2022 · International Immunopharmacology
  13. The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models
    Hiram Tendilla‐Beltrán, Nydia del Carmen Sanchez-Islas, Mauricio Marina-Ramos, Juan Carlos Leza, Gonzalo Flores · 2020 · Progress in Neurobiology
  14. Towards a neurodynamical understanding of the prodrome in schizophrenia
    Emmi Mikanmaa, Tineke Grent-‘t-Jong, Lingling Hua, Marc Recasens, Hanna Thuné, Peter J. Uhlhaas · 2017 · NeuroImage
  15. NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity
    Luisa A. Hasam‐Henderson, Grace C. Gotti, Michele Mishto, Constantin Klisch, Zoltán Gerevich, Jörg R. P. Geiger, Richard Kovács · 2018 · Scientific Reports
  16. Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
    Alexei M. Bygrave, Kasyoka Kilonzo, Dimitri Michael Kullmann, David M. Bannerman, Dennis Kätzel · 2019 · Frontiers in Psychiatry
  17. Experimental Chronic Prostatitis/Chronic Pelvic Pain Syndrome Increases Anxiety‐Like Behavior: The Role of Brain Oxidative Stress, Serum Corticosterone, and Hippocampal Parvalbumin‐Positive Interneurons
    Nikola Šutulović, Željko Grubač, Sonja R. Suvakov, Djurdja Jerotić, Nela Puškaš, Djuro Μacut, Aleksandra Rašić-Marković, Tatjana P. Simic, Olivera P. Stanojlović, Dragan Hrnčić · 2021 · Oxidative Medicine and Cellular Longevity
  18. Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility
    David D. Aguilar, Andrea Giuffrida, Daniel J. Lodge · 2018 · The International Journal of Neuropsychopharmacology
  19. Perineuronal Nets and Metal Cation Concentrations in the Microenvironments of Fast-Spiking, Parvalbumin-Expressing GABAergic Interneurons: Relevance to Neurodevelopment and Neurodevelopmental Disorders
    Jessica A. Burket, Jason D. Webb, Stephen I. Deutsch · 2021 · Biomolecules
  20. Distinct effects of interleukin-6 and interferon-γ on differentiating human cortical neurons
    Annie Kathuria, Kara Lopez-Lengowski, Joshua L. Roffman, Rakesh Karmacharya · 2022 · Brain Behavior and Immunity
  21. Levetiracetam Attenuates Adolescent Stress-induced Behavioral and Electrophysiological Changes Associated With Schizophrenia in Adult Rats
    Andreza Manzato Cavichioli, Thamyris Santos‐Silva, Anthony A. Grace, Francisco Silveira Guimarães, Felipe V. Gomes · 2022 · Schizophrenia Bulletin
  22. Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
    Ruri Okubo, Motohiro Okada, Eishi Motomura · 2024 · Biomolecules
  23. Absence of parvalbumin increases mitochondria volume and branching of dendrites in inhibitory Pvalb neurons in vivo: a point of convergence of autism spectrum disorder (ASD) risk gene phenotypes
    Lucia Janickova, Karin Farah Rechberger, Lucas Wey, Beat Schwaller · 2020 · Molecular Autism
  24. Are CB2 Receptors a New Target for Schizophrenia Treatment?
    Isadora Lopes Cortez, Naielly Rodrigues da Silva, Francisco Silveira Guimarães, Felipe V. Gomes · 2020 · Frontiers in Psychiatry
  25. Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis
    Alex J. Murray, Clara S. Humpston, Martin Wilson, Jack C Rogers, Mohammad Zia Ul Haq Katshu, Peter Francis Liddle, Rachel Upthegrove · 2023 · Brain Behavior and Immunity
  26. DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?
    Piotr Lech Czarny, Katarzyna I. Białek, Sylwia Ziółkowska, Justyna Strycharz, Tomasz Śliwiński · 2019 · Mutagenesis
  27. Chondroitin sulfate proteoglycans: key modulators of neuronal plasticity, long-term memory, neurodegenerative, and psychiatric disorders
    Xin Yang · 2020 · Reviews in the Neurosciences
  28. Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy
    Ethan S. Burstein · 2021 · CNS Drugs
  29. Development, Diversity, and Death of MGE-Derived Cortical Interneurons
    Rhîannan H. Williams, Therese Riedemann · 2021 · International Journal of Molecular Sciences
  30. Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis
    Peter Falkai, Moritz J. Rossner, Florian J. Raabe, Elias M. Wagner, Daniel Keeser, Isabel Maurus, Lukas Roell, Emily Chang, Johanna Seitz‐Holland, Thomas G. Schulze et al. · 2023 · Schizophrenia Bulletin
  31. D-serine reconstitutes synaptic and intrinsic inhibitory control of pyramidal neurons in a neurodevelopmental mouse model for schizophrenia
    Xiaoqin Zhang, Le Xu, Xinyi Zhu, Zi-Hang Tang, Yi-Bei Dong, Zhipeng Yu, Qing Sen Shang, Zhengchun Wang, Haowei Shen · 2023 · Nature Communications
  32. Hyaluronan degradation and release of a hyaluronan-aggrecan complex from perineuronal nets in the aged mouse brain
    Sugitani, Kei, Egorova, Diana, Mizumoto, Shuji, Nishio, Shunsuke, Yamada, Shuhei, Kitagawa, Hiroshi, Oshima, Kenzi, Nadano, Daita, Matsuda, Tsukasa, Miyata, Shinji · 2021 · Biochimica et Biophysica Acta (BBA) - General Subjects
  33. The Neurometabolic Basis of Mood Instability: The Parvalbumin Interneuron Link—A Systematic Review and Meta-Analysis
    Antonello Pinna, Alessandro Colasanti · 2021 · Frontiers in Pharmacology
  34. Associations between urinary biomarkers of oxidative stress in the third trimester of pregnancy and behavioral outcomes in the child at 4 years of age
    Anna‐Sophie Rommel, Ginger L. Milne, Emily S. Barrett, Nicole R. Bush, Ruby H.N. Nguyen, Sheela Sathyanarayana, Shanna Helen Swan, Kelly K. Ferguson · 2020 · Brain Behavior and Immunity
  35. Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia
    Breno Fiúza Cruz, Salvina Maria de Campos-Carli, Amanda Margarida de Oliveira, Camila Bernardo de Brito, Zélia Menezes Garcia, Raquel Duque do Nascimento Arifa, Danielle G. Souza, Antônio Lúcio Teixeira, João Vinícius Salgado · 2021 · Psychiatry Research
  36. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
    David D. Aguilar, Leana K. Radzik, Felipe L. Schiffino, Oluwarotimi O. Folorunso, Mark R. Zielinski, Joseph T. Coyle, Darrick T. Balu, James M. McNally · 2021 · Scientific Reports
  37. Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia
    Deborah K. Park, Samuel Petshow, Margarita Anisimova, Eden V. Barragan, John A. Gray, Ivar S. Stein, Karen Zito · 2022 · Neurobiology of Disease
  38. Neonatal Oxidative Stress Impairs Cortical Synapse Formation and GABA Homeostasis in Parvalbumin‐Expressing Interneurons
    Till Scheuer, Stefanie Endesfelder, Elena auf dem Brinke, Christoph Bührer, Thomas Schmitz · 2022 · Oxidative Medicine and Cellular Longevity
  39. Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat model: assessing the role of oxidative stress and neuroinflammation interaction
    Larissa Allgäuer, Jan-Harry Cabungcal, Catherine Yzydorczyk, Kim Q., Daniella Dwir · 2023 · Translational Psychiatry
  40. Deficits in Glutamic Acid Decarboxylase 67 Immunoreactivity, Parvalbumin Interneurons, and Perineuronal Nets in the Inferior Colliculus of Subjects With Schizophrenia
    Victor W. Kilonzo, Robert A. Sweet, Jill R. Glausier, Matthew W. Pitts · 2020 · Schizophrenia Bulletin
  41. Circadian time‐ and sleep‐dependent modulation of cortical parvalbumin‐positive inhibitory neurons
    Fangjiao Zong, Xia Min, Yan Zhang, Yuke Li, Xueting Zhang, Yang Liu, Kaiwen He · 2022 · The EMBO Journal
  42. Visual Attention Decits in Schizophrenia Can Arise From Inhibitory Dysfunction in Thalamus or Cortex
    Yohan J. John, Basilis Zikopoulos, Daniel H. Bullock, Helen Barbas · 2018 · Computational Psychiatry
  43. Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study
    Xirong Li, Mei Hong Xiu, Xiao Ni Guan, Yue Chan Wang, Jun Wang, Edison Leung, Xiangyang Zhang · 2021 · Neurotherapeutics
  44. Ketamine-Treatment During Late Adolescence Impairs Inhibitory Synaptic Transmission in the Prefrontal Cortex and Working Memory in Adult Rats
    Miguel Ángel Pérez, Camila Morales, Odra Santander, Francisca García, Isabel Gómez, Valentín Peñaloza‐Sancho, Pablo Fuentealba, Alexies Dagnino‐Subiabre, Pablo R. Moya, Marco Fuenzalida · 2019 · Frontiers in Cellular Neuroscience
  45. Developmental oxidative stress leads to T-type Ca2+ channel hypofunction in thalamic reticular nucleus of mouse models pertinent to schizophrenia
    Corinne El Khoueiry, Jan-Harry Cabungcal, Zita Rovó, Margot Fournier, Kim Q., Pascal Steullet · 2022 · Molecular Psychiatry
  46. Balance of activity during a critical period tunes a developing network
    Iain Hunter, Bramwell Coulson, Tom Pettini, Jacob J. Davies, Jill Parkin, Matthias Landgraf, Richard Baines · 2023 · eLife
  47. Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses
    Sebastian Reyes-Lizaola, Ulises Luna-Zarate, Hiram Tendilla‐Beltrán, Julio César Morales‐Medina, Gonzalo Flores · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  48. Implication of the glutamate–cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis
    Margot Fournier, Aline Monin, Carlotta Ferrari, Philipp Baumann, Philippe Conus, K. Do · 2017 · Schizophrenia
  49. Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats
    Magdalena Górny, Agnieszka Wnuk, Adrianna Kamińska, Kinga Kamińska, Grażyna Chwatko, Anna Bilska‐Wilkosz, Małgorzata Iciek, Małgorzata Kajta, Zofia Rogóż, Elżbieta Lorenc‐Koci · 2019 · Molecules
  50. Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction
    Shekib A. Jami, Scott Cameron, Jonathan M. Wong, Emily R. Daly, A. Kimberley McAllister, John A. Gray · 2021 · Journal of Neurophysiology
  51. Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial
    Gangrui Hei, Robert C. Smith, Ranran Li, Jianjun Ou, Xueqing Song, Yingjun Zheng, Yiqun He, Jen Arriaza, Jed W. Fahey, Brian S. Cornblatt et al. · 2022 · Schizophrenia Bulletin Open
  52. Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
    Giorgio Pistis, Javier Vázquez-Bourgón, Margot Fournier, Raoul Jenni, Martine Cleusix, Sergi Papiol, Sophie E. Smart, Antonio F. Pardiñas, James Walters, James Hunter MacCabe et al. · 2022 · Molecular Psychiatry
  53. Hyperactive MEK1 Signaling in Cortical GABAergic Neurons Promotes Embryonic Parvalbumin Neuron Loss and Defects in Behavioral Inhibition
    Michael C. Holter, Lauren T. Hewitt, Kenji J. Nishimura, Sara J. Knowles, George R. Bjorklund, Shiv Shah, Noah Fry, Katherina P. Rees, Tanya A. Gupta, Carter W. Daniels et al. · 2020 · Cerebral Cortex
  54. Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia
    P. J. Michael Deans, Kristen Brennand · 2021 · Current Opinion in Neurobiology
  55. Generation of cerebral cortical GABAergic interneurons from pluripotent stem cells
    Megan Fitzgerald, Nathaniel P. Sotuyo, David J. Tischfield, Stewart A. Anderson · 2020 · Stem Cells
  56. Trimester-specific associations of maternal exposure to disinfection by-products, oxidative stress, and neonatal neurobehavioral development
    Chong Liu, Carmen Messerlian, Ying‐Jun Chen, Vicente Mustieles, Lili Huang, Yang Sun, Yan-Ling Deng, Ying-Hui Cheng, Jing Liu, A-Mei Liu et al. · 2021 · Environment International
  57. Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
    Chien-Yi Kuo, Chieh‐Hsin Lin, Hsien‐Yuan Lane · 2022 · CNS Drugs
  58. N‐Methyl‐ d ‐aspartate receptor co‐agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse
    Matthew D. Puhl, Rajeev I. Desai, Shunsuke Takagi, Kendall Taylor Presti, Michelle R. Doyle, Rachel J. Donahue, Samantha M. Landino, Jack Bergman, William A. Carlezon, Joseph T. Coyle · 2017 · Addiction Biology
  59. Cell Type-Specific Oxidative Stress Genomic Signatures in the Globus Pallidus of Dopamine-Depleted Mice
    Alyssa J. Lawler, Ashley R. Brown, Rachel S. Bouchard, Noelle Toong, Yeonju Kim, Nitinram Velraj, Grant A Fox, Michael Kleyman, Byungsoo Kang, Aryn H. Gittis et al. · 2020 · Journal of Neuroscience
  60. Passing the torch: The ascendance of the glutamatergic synapse in the pathophysiology of schizophrenia
    Joseph T. Coyle · 2024 · Biochemical Pharmacology
  61. Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity
    Rekha Jagadapillai, Xiaolu Qiu, Kshama Ojha, Zhu Li, Ayman S El-Baz, Shipu Zou, Evelyne Gozal, Gregory Neal Barnes · 2022 · Cells
  62. Parvalbumin interneuron loss mediates repeated anesthesia-induced memory deficits in mice
    Patricia Soriano Roque, Carolina Thörn Pérez, Mehdi Hooshmandi, Calvin Wong, Mohammad Javad Eslamizade, Shilan Heshmati, Nicole Brown, Vijendra K. Sharma, Kevin C. Lister, Vanessa Goyon et al. · 2022 · Journal of Clinical Investigation
  63. The Role of Parvalbumin Interneurons in Autism Spectrum Disorder
    Yiwei Yao, Qian Li · 2024 · Journal of Neuroscience Research
  64. Nutritional Intervention for Developmental Brain Damage: Effects of Lactoferrin Supplementation in Hypocaloric Induced Intrauterine Growth Restriction Rat Pups
    Yohan van de Looij, Camille Larpin, Jan-Harry Cabungcal, Eduardo Farias Sanches, Audrey Toulotte, Kim Q., Stéphane Vladimir Sizonenko · 2019 · Frontiers in Endocrinology
  65. Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats
    Hiram Tendilla‐Beltrán, Heriberto Coatl-Cuaya, Silvia Meneses-Prado, Rubén Antonio Vázquez‐Roque, Eduardo Brambila, Miguel Tapia Rodríguez, David Martín‐Hernández, Linda Garcés‐Ramírez, José L. M. Madrigal, Juan Carlos Leza et al. · 2021 · Schizophrenia Research
  66. Hippocampal Sequencing Mechanisms Are Disrupted in a Maternal Immune Activation Model of Schizophrenia Risk
    Lucinda J. Speers, Kirsten R. Cheyne, Elena Cavani, T Hayward, Robert Schmidt, David K. Bilkey · 2021 · Journal of Neuroscience
  67. Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats
    M. A. Lech, M. Leśkiewicz, K. Kamińska, Z. Rogóż, E. Lorenc-Koci · 2021 · International Journal of Molecular Sciences
  68. Disorganization of Oscillatory Activity in Animal Models of Schizophrenia
    Lucinda J. Speers, David K. Bilkey · 2021 · Frontiers in Neural Circuits
  69. Identification of Vulnerable Interneuron Subtypes in 15q13.3 Microdeletion Syndrome Using Single-Cell Transcriptomics
    Susmita Malwade, Janina Gasthaus, Carmelo Bellardita, Matej Andelic, Borna Moric, Irina Korshunova, Ole Kiehn, Navneet A. Vasistha, Konstantin Khodosevich · 2021 · Biological Psychiatry
  70. Cognitive Impairment and Psychopathology Are Related to Plasma Oxidative Stress in Long Term Hospitalized Patients With Chronic Schizophrenia
    Man Li Yang, Jin Li, Haidong Yang · 2022 · Frontiers in Psychiatry
  71. Comparison of Hematological Parameters Between First-Episode Schizophrenia and Anti-NMDAR Encephalitis
    Kai Huang, Yamei Tang, Zhiheng Chen, Shan Ding, Hongtao Zeng, Yuxu Zhao, Qi Yu, Yong Liu · 2022 · Frontiers in Cell and Developmental Biology
  72. Parvalbumin-Deficiency Accelerates the Age-Dependent ROS Production in Pvalb Neurons in vivo: Link to Neurodevelopmental Disorders
    Lucia Janickova, Beat Schwaller · 2020 · Frontiers in Cellular Neuroscience
  73. Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies
    João Roberto Lisboa, Olga Costa, Gustavo Henrique Pakes, Débora Akemi Endo Colodete, Felipe V. Gomes · 2024 · Schizophrenia Research
  74. Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice
    Andrea Balla, Stephen D. Ginsberg, Atheir I. Abbas, Henry W. Sershen, Daniel C. Javitt · 2020 · Biomarkers in Neuropsychiatry
  75. Antioxidant treatment ameliorates prefrontal hypomyelination and cognitive deficits in a rat model of schizophrenia
    Dorien A. Maas, Vivian D. Eijsink, Josephus A. van Hulten, Radmila Panic, Peter De Weerd, Judith Regina Homberg, Astrid Vallès, Brahim Nait‐Oumesmar, Gerard J.M. Martens · 2021 · Neuropsychopharmacology
  76. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia
    Narasimha Murthy Beeraka, Marco Ávila-Rodriguez, Gjumrakch M. Aliev · 2022 · Molecular Neurobiology
  77. Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case-control study
    Haidong Yang, Caiyi Zhang, Man Li Yang, Junjun Liu, Yuting Zhang, Dongliang Liu, Xiaobin Zhang · 2024 · BMC Psychiatry
  78. Maternal P7C3-A20 Treatment Protects Offspring from Neuropsychiatric Sequelae of Prenatal Stress
    Rachel E. Schroeder, Preethy S. Sridharan, Lynn T. Nguyen, Alexandra Loren, Noelle Sevilir Williams, Kavitha Priya Kettimuthu, Coral J. Cintrón-Pérez, Edwin Vázquez‐Rosa, Andrew A. Pieper, Hanna Elizabeth Stevens · 2021 · Antioxidants and Redox Signaling
  79. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease
    Glen E. Kisby, Peter S. Spencer · 2021 · Frontiers in Neuroscience
  80. PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation
    Carmela Belardo, Nicola Alessio, Martina Pagano, Emanuela De Dominicis, Rosmara Infantino, Michela Perrone, Monica Iannotta, Umberto Galderisi, Barbara Rinaldi, Damiana Scuteri et al. · 2022 · Neuropharmacology
  81. Developmental disruption to the cortical transcriptome and synaptosome in a model of SETD1A loss-of-function
    Nicholas E. Clifton, Matthew L. Bosworth, Niels Haan, Elliott Rees, Peter Holmans, Lawrence S. Wilkinson, Anthony R Isles, Mark O. Collins, Jérémy Hall · 2022 · Human Molecular Genetics
  82. Parvalbumin as a sex-specific target in Alzheimer’s disease research – A mini-review
    Dylan J. Terstege, Jonathan R. Epp · 2023 · Neuroscience & Biobehavioral Reviews
  83. Degradation of Perineuronal Nets in the Ventral Hippocampus of Adult Rats Recreates an Adolescent-Like Phenotype of Stress Susceptibility
    Débora Akemi Endo Colodete, Anthony A. Grace, Francisco Silveira Guimarães, Felipe V. Gomes · 2024 · Biological Psychiatry Global Open Science
  84. Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome
    Brianna K. Unda, Leon Chalil, Sehyoun Yoon, Savannah Kilpatrick, Courtney L. Irwin, Sansi Xing, Nadeem Murtaza, Anran Cheng, Chad O. Brown, Alexandria Afonso et al. · 2023 · Molecular Psychiatry
  85. Modulatory Effects of Monoamines and Perineuronal Nets on Output of Cerebellar Purkinje Cells
    Moritoshi Hirono, Fuyuki Karube, Yuchio Yanagawa · 2021 · Frontiers in Neural Circuits
  86. Reduced TMS-evoked fast oscillations in the motor cortex predict the severity of positive symptoms in first-episode psychosis
    Francesco Luciano Donati, Rachel E. Kaskie, Catarina Cardoso Reis, Armando D’Agostino, Adenauer Girardi Casali, Fabio Ferrarelli · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  87. Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats
    Suzanne Estaphan, Alexandrina-Ștefania Curpăn, Dalia Khalifa, Laila Rashed, Andrei Ciobîcă, Adrian Cantemir, Alin Stelian Ciobica, Constantin Truş, Mahmoud Ali, Asmaa Mohammed ShamsEldeen · 2021 · Brain Sciences
  88. Adolescent Stress-Induced Ventral Hippocampus Redox Dysregulation Underlies Behavioral Deficits and Excitatory/Inhibitory Imbalance Related to Schizophrenia
    Thamyris Santos‐Silva, Caio Fábio Baeta Lopes, Doğukan Hazar Ülgen, Danielle Aparecida Guimarães, Francisco Silveira Guimarães, Luciane C. Alberici, Carmen Sandi, Felipe V. Gomes · 2024 · Schizophrenia Bulletin
  89. The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders
    Annalisa Palmisano, Siddhartha Pandit, Carmelo Luca Smeralda, Ilya Demchenko, Símone Rossi, Lorella Battelli, Davide Rivolta, Venkat Bhat, Emiliano Santarnecchi · 2024 · Life
  90. Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity
    Ludovica Mana, Marc Schwartz-Palleja, Manel Vila‐Vidal, Gustavo Deco · 2024 · Schizophrenia Research
  91. Introducing the Role of Genotoxicity in Neurodegenerative Diseases and Neuropsychiatric Disorders
    Glen E. Kisby, David M. Wilson, Peter S. Spencer · 2024 · International Journal of Molecular Sciences
  92. Antioxidant potential of Hippophae rhamnoides L. extracts obtained with green extraction technique
    Anna Muzykiewicz-Szymańska, Joanna Zielonka-Brzezicka, Adam Klimowicz · 2018 · Herba Polonica
  93. Poly I:C‐induced maternal immune challenge reduces perineuronal net area and raises spontaneous network activity of hippocampal neurons in vitro
    David Wegrzyn, Marie Pierre Manitz, Michael Kostka, Nadja Freund, Georg Juckel, Andréas Faissner · 2020 · European Journal of Neuroscience
  94. Juvenile Selenium Deficiency Impairs Cognition, Sensorimotor Gating, and Energy Homeostasis in Mice
    Victor W. Kilonzo, Alexandru R. Sasuclark, Daniel J. Torres, Celine Coyle, Jennifer M. Pilat, Christopher S. Williams, Matthew W. Pitts · 2021 · Frontiers in Nutrition
  95. Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
    Haixia Liu, Hua Liu, Shuling Jiang, Lei Su, Yi Lu, Zhenli Chen, Xiaojing Li, Xirong Li, Xuemei Wang, Meihong Xiu et al. · 2021 · Current Neuropharmacology
  96. Evaluating the effect of black myrobalan on cognitive, positive, and negative symptoms in patients with chronic schizophrenia: A randomized, double‐blind, placebo‐controlled trial
    Mohammad Banazadeh, Mitra Mehrabani, Nabi Banazadeh, Fatemeh Dabaghzadeh, Farzad Shahabi · 2021 · Phytotherapy Research
  97. Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1
    Junyang Wang, Shiwu Li, Xiaoyan Li, Jiewei Liu, Jinfeng Yang, Yifan Li, Wenqiang Li, Yongfeng Yang, Jiao Li, Rui Chen et al. · 2022 · Brain
  98. Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes
    Malosree Maitra, Haruka Mitsuhashi, Reza Rahimian et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Differential Impact of Adolescent or Adult Stress on Behavior and Cortical Parvalbumin Interneurons and Perineuronal Nets in Male and Female Mice
    Thamyris Santos‐Silva, Beatriz Kinchin Souza, Débora Akemi Endo Colodete, Lara Ramos Campos, Thaís Santos Almeida Lima, Francisco S Guimarães, Felipe V Gomes · 2024 · The International Journal of Neuropsychopharmacology
  100. N-acetylcysteine treatment mitigates loss of cortical parvalbumin-positive interneuron and perineuronal net integrity resulting from persistent oxidative stress in a rat TBI model
    Mustafa Qadir Hameed, Nathaniel Hodgson, Henry H.C. Lee, Andrés Pascual-Leone, Paul MacMullin, Ali Jannati, Sameer C. Dhamne, Takao K. Hensch, Alexander Rotenberg · 2022 · Cerebral Cortex